Method of using methylene blue nanoparticle for detecting cancer by bioimaging
AssigneeD. R. Nano Co., Ltd.
InventorsSehoon Kim, Ick Chan Kwon, Sangyoup Lee
Life of this patent
Estimating the term…
Loading patent…
AssigneeD. R. Nano Co., Ltd.
InventorsSehoon Kim, Ick Chan Kwon, Sangyoup Lee
Estimating the term…
The present invention discloses a method for diagnosing and detecting cancer by bioimaging using methylene blue nanoparticle as a contrasting agent. The methylene blue nanoparticle of the present invention for use as a topical cancer targeting phototherapeutic agent is composed of only a material of which the composition is clinically used or derived from human bodies, and thus a nanopreparation in which a barrier to clinical entry is low and the possibility of commercialization is very high, exhibits near-infrared fluorescence along with cancer targeting property, a capacity of generating a singlet oxygen and the like. Therefore, the methylene blue nanoparticle in the present invention is able to detect cancerous cells by emitting visible light in irradiation conditions.
A method for detecting of cancer using methylene blue nanoparticles, the method comprising steps of:
A method of determining a surgical resection margin by using methylene blue nanoparticles for surgically treating of cancer, and the method comprising steps of;
Dependencies are inferred from the claim text.